← Back to Search

Yoga-Based Therapy for Post-COVID Syndrome (MYS LCOVID-19 Trial)

N/A
Waitlist Available
Led By Jennifer Portz, PhD, MSW
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 8
Awards & highlights

MYS LCOVID-19 Trial Summary

This trial will assess the feasibility of a mobile therapy for long COVID patients to help manage fatigue, pain, mood and quality of life.

Who is the study for?
This trial is for long COVID patients who can stand (with or without help), speak English, and give informed consent. They should be living in the community and referred to UC Health Integrated Medicine Clinic. Those with regular yoga practice or recent self-management education, as well as those with cognitive issues affecting decision-making, cannot join.Check my eligibility
What is being tested?
The study tests MY-Skills Mobile, a program combining Yoga and Self-Management Skills aimed at reducing fatigue, pain, mood swings, and improving life quality for Long COVID sufferers. It will check how practical and acceptable this mobile intervention is.See study design
What are the potential side effects?
Since this intervention involves yoga and self-management skills training rather than medication or invasive procedures, side effects are minimal but may include muscle soreness or strain from new physical activities.

MYS LCOVID-19 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility- Attrition
Feasibility- Recruitment
Feasibility- Use
+1 more
Secondary outcome measures
Brief Pain Inventory
PROMIS Fatigue
Short Form 36
+1 more

MYS LCOVID-19 Trial Design

1Treatment groups
Experimental Treatment
Group I: MY-Skills MobileExperimental Treatment1 Intervention
8-week intervention merging yoga and self-management offered via secure remote tools including Zoom (video-conferencing software), Canvas (education software), and Qualtrics (survey software) that can be accessed via a computer or tablet. Each participant will have an initial yoga therapy individual session prior to start of group yoga. Group yoga is offered synchronously via Zoom two times per week for 60 minutes (120 minutes per week). The self-management content is delivered primarily through asynchronous tools that include educational videos, facilitated discussion boards, and interactive activities for goal setting, monitoring goals, and problem-solving practice. Self-management content is reiterated during the bi-weekly synchronous sessions, discussed as a group, and mantras are carried through both practices.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MY-Skills for Long COVID
2023
N/A
~20

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,752 Previous Clinical Trials
2,165,583 Total Patients Enrolled
19 Trials studying COVID-19
18,268 Patients Enrolled for COVID-19
Jennifer Portz, PhD, MSWPrincipal InvestigatorUniversity of Colorado, Denver
1 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

MY-Skills for Long COVID Clinical Trial Eligibility Overview. Trial Name: NCT05697042 — N/A
COVID-19 Research Study Groups: MY-Skills Mobile
COVID-19 Clinical Trial 2023: MY-Skills for Long COVID Highlights & Side Effects. Trial Name: NCT05697042 — N/A
MY-Skills for Long COVID 2023 Treatment Timeline for Medical Study. Trial Name: NCT05697042 — N/A
~7 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top